INTRODUCTION {#sec1-1}
============

Last three decades have been very challenging, especially due to the global menace of developing antibiotic resistance.\[[@ref1]\] Newer drugs are being discovered with millions and billions being invested in drug research.\[[@ref2]\] Instead, the need for developing newer alternatives or unexplored properties of existing agents which can enhance the activity of pre-existing drugs or antibiotics is definitely a viable option.\[[@ref3]\] For instance, in the field of Endodontics, both pediatric and adult, intracanal medicaments are commonly used for proper disinfection of the root canals, especially in refractory cases. Proper disinfection is the mainstay for successful endodontic therapy and it is achieved through the collective effects of biomechanical preparation, irrigation, and intracanal medication.\[[@ref4][@ref5][@ref6]\]

Furthermore, previous studies have shown that bacteria in infected root canals and also periapical tissues (especially furcation area in primary molars) reside deep within dentine, cementum, and periapical tissues too.\[[@ref7][@ref8]\] In order to reach these areas effectively, enhanced penetration is attained by means of intracanal medicaments used along with carriers or vehicles, for example, propylene glycol.\[[@ref9]\]

One of the properties which have been under-investigated is whether these vehicles or the so-called "excipients" in Pharmaceutics have antimicrobial property or activity on their own. If they really possess antimicrobial activity, they can be used as an effective alternative for disinfection of root canals, with reduced probability of development of antibiotic resistance. In view of the above-mentioned facts, we planned to study the antimicrobial activity of the vehicles propylene glycol, glycerin, polyethylene glycol 400 (PEG 400), polyethylene glycol 1000 (PEG 1000), and a combination of propylene glycol and PEG 400, as this might shed some light on the ideal vehicle for intracanal medicaments. Polyethylene glycol is also referred to as "Macrogol" and the number denotes its molecular weight. Higher the number, higher is its viscosity.\[[@ref10]\] The combination of propylene glycol with Macrogol was first used in dentistry *in vivo* by Takushige *et al*., whereas PEG 1000 was used *in vitro* recently by Carreira *et al*.\[[@ref11][@ref12]\] To the best of our knowledge and literature search, no study of the bactericidal activity of these vehicles and their comparison has been conducted till date.

MATERIALS AND METHODS {#sec1-2}
=====================

This study was carried out in Dr Prabhakar Kore Basic Science Research Centre, KLE University, Belgaum. It was approved by the Institutional Review Board of KLE University (Ref No. KLEU/Ethic/14-15/D-73) and it is a part of an ongoing *ex vivo* study. The susceptibility of the test organisms to propylene glycol, glycerine, PEG 400, PEG 1000, and propylene glycol with PEG 400 was assessed using broth dilution assay, as minimum inhibitory concentration (MIC) can be readily converted to the minimum bactericidal concentration (MBC). Triplicates were performed for each of the standard strains.

Culture media: Brain Heart Infusion (BHI) brothTest organisms: Four micro-organisms were selected for the study: *Streptococcus mutans* American Type Culture Collection (ATCC) 25175, *Staphylococcus aureus* ATCC 12598, *Enterococcus faecalis* ATCC 35550, and *Escherichia coli* ATCC 25922 \[[Figure 1](#F1){ref-type="fig"}\]. All microorganisms were previously subcultured in appropriate media and under gaseous conditions to confirm their purity at 35°C for 48 h prior to testing of the vehiclesFigure 1Standard strains against which bactericidal activity of the five vehicles was checked: (a) *Streptococcus mutans* ATCC 25175; (b) *Staphylococcus aureus* ATCC 12598; (c) *Enterococcus faecalis* ATCC 35550; (d) *Escherichia coli* ATCC 25922Inoculum preparation: The growth method or the log phase method was performed as follows. At least three to five well-isolated colonies of the same morphological type were selected from an agar culture plate. The top of each colony was touched with a loop, and the growth was transferred into a tube containing 4--5 ml of BHI broth. The broth culture was incubated at 35°C for 2--6 h until it achieved the turbidity of the 0.5 McFarland standard. The turbidity of actively growing broth culture was adjusted with broth to obtain a final turbidity optically comparable to that of the 0.5 McFarland standard, done visually by comparing the inoculum tube and the standard against a white card with contrasting black linesBroth dilution method: A total of 10 tubes were taken and nine dilutions of the vehicle were done with BHI for MIC and MBC. In the initial tube, only 200 μl of vehicle was added. For further dilutions, 200 μl of BHI broth was added to the next nine tubes separately. In the second tube, 200 μl of vehicle was added which already contained 200 μl of BHI broth. This was considered as 10^−1^ dilution. From the 10^−1^ diluted tube, 200 μl was transferred to the second tube to make 10^−2^ dilution. The serial dilution was repeated up to 10^−8^ dilution for each vehicle. From the maintained stock cultures of the required organisms, 5 μl was taken and added to 2 ml of BHI broth. In each serially diluted tube, 200 μl of the above culture suspension was added. The last tube contained only the media and the culture suspension, i.e. the growth control. The tubes were kept for incubation for 24 h at 37°C in bacteriological incubator and observed for turbidity \[[Figure 2](#F2){ref-type="fig"}\]Figure 2Susceptibility of *Eschericia coli* ATCC 25922 to (a) Propylene glycol, (b) Glycerine, (c) PEG 400, (d) PEG 1000 and (e) Propylene glycol with PEG 400 assessed using Broth dilution assayMBC: After recording the lowest concentration inhibiting the growth of organisms as MIC, all the tubes not showing visible growth were subcultured on BHI agar along with the control tube, i.e., growth control, and incubated overnight. The amount of growth was noted; no growth indicated the whole inoculum was killed and this highest dilution showing 99.99% inhibition was recorded as MBC \[[Figure 3](#F3){ref-type="fig"}\]\[[@ref13]\]Figure 3Minimum Bactericidal Concentration (MBC) of *Eschericia coli* ATCC 25922 to (a) Propylene glycol, (b)glycerine, (c) PEG 400, (d) PEG 1000 and (e) Propylene glycol with PEG 400 was assessed after being subcultured on BHI agarTriplicates were performed for each of the standard strains. The experimental data were collected and statistically analyzed using Fisher\'s exact test.

RESULTS {#sec1-3}
=======

The MBC results for the vehicles are shown in [Table 1](#T1){ref-type="table"}. The results showed that all vehicles did exhibit bactericidal activity on the selected microorganisms at different concentrations. Out of all the vehicles, PEG 1000 was the most effective antimicrobial vehicle while glycerine was the least effective on the basis of its MIC. Propylene glycol was the second most effective against all microorganisms except *Sta. aureus*.

###### 

Bactericidal activity of vehicles against ATCC strains of *Str. mutans*, *Sta. aureus*, *En. faecalis* and *Es. coli*
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Among all the ATCC strains of microorganisms, *Str. mutans* and *Es. coli* were the most susceptible to the vehicles, *En. faecalis* exhibited intermediate susceptibility, and *Sta. aureus* was the most resistant to all the vehicles.

The combination of propylene glycol and PEG 400 did not show any synergistic antimicrobial activity and, in fact, its efficacy decreased against *Str. mutans*, *En. faecalis*, and *Es. coli*, in comparison to propylene glycol alone.

PEG 1000 was most effective bactericidal agent against *Str. mutans* and *Es. coli* among all the five vehicles and the difference was statistically significant (Fisher\'s exact test: *P* = 0.003 and *P* = 0.004, respectively). For *Sta. aureus* and *En. faecalis*, none of the five vehicles showed statistically significant difference in their bactericidal activity (Fisher\'s exact test: *P* = 1 and *P* = 0.326, respectively).

DISCUSSION {#sec1-4}
==========

In endodontic therapy, few cases do not respond to the conventional therapy in the pediatric and adult Endodontics. This difficulty to treat such refractory cases may be due to many reasons such as anatomic variation, presence of biofilms, and development of antibiotic resistance.\[[@ref9]\] To overcome the problem of the global menace of developing antibiotic resistance, the use of alternative medications and substances or a combination of pharmaceutical excipients is suggested to increase the spectrum of antimicrobial action.\[[@ref3]\] The most difficult to tackle is facultative anaerobes, as they are the ones that develop resistance most of the time.\[[@ref14]\]

The use of intracanal medicaments becomes mandatory in Endodontics as many non-vital and abscessed teeth lack blood circulation. As a result of this, systemic antibiotics fail to reach the site of infection and, hence, such infections cannot be treated.\[[@ref15]\] Also, local drug delivery and sustained release along with better diffusion into the surrounding periradicular tissues may prove to be an added advantage.\[[@ref9][@ref16]\] The vehicles used to dispense the intracanal medicaments have a direct influence on the release, time of onset of action of the medicament, penetration of the intracanal medicaments into dentinal tubules, and also the dissociation of drugs. The *in vitro* bactericidal activity of a variety of glycols, especially monopropylene, dipropylene, and triethylene, has been investigated more extensively. The bactericidal activity of PEG 400 had been studied almost three decades ago by Vaamonde *et al*. in 1982 and Chirfe *et al*. in 1983,\[[@ref17]\] whereas the antimicrobial effect of PEG 1000 has been studied only recently.\[[@ref12]\] The antimicrobial activity of PEG 1000 might be related to the hydrophilic property of PEG. Removal of water possibly does not allow microbial growth, as a certain amount of water is essential for the multiplication and development of microbes.\[[@ref12]\] It is interesting to note that PEG 1000, like propylene glycol, also allowed greater dentinal penetration when combined with intracanal medicaments.\[[@ref9]\] After a thorough review of literature, we have not come across a single article which explores and compares the bactericidal activity of these pharmaceutical excipients.

Also, after a series of *in vitro* and *in situ* studies, the Cariology Research Unit of the Niigata University School of Dentistry developed the concept of 3M-MP, in which 3M stands for triple mix of antibiotics and MP stands for Macrogol, i.e. polyethylene glycol, and propylene glycol, respectively.\[[@ref11][@ref18]\] This group of investigators have carried out extensive research on the most ideal antibiotics to be used for disinfection of dentinal tubules, but there is only one such study regarding penetration of propylene glycol as vehicle for intracanal medicament.\[[@ref9]\] Propylene glycol is a known antimicrobial and is an effective preservative.\[[@ref19]\] A recent article by Carreira *et al*. published in 2007 has thrown some light on the phenomenon of synergism in bactericidal activity, which was observed in Ciprofloxacin--PEG 1000 association, Metronidazole--PEG 1000 association, and Ciprofloxacin--Metronidazole--PEG 1000 combination. Also, PEG 400 produced severe plasmolysis, cell wall collapse, and finger-like extrusions in *Klebsiella pneumonia*.\[[@ref20]\] Promising results have been shown by PEG-coated nanoparticles which were found to be most effective in killing *Es. coli*, *Sta. aureus*, and multi-drug resistant clinical isolates of *Shigella* spp. and *Vibrio cholera*.\[[@ref21]\] Of all the vehicles being used in Endodontics, camphorated monochlorophenol (CMCP) is effective but tissue toxic, whereas distilled water possesses no antimicrobial activity.\[[@ref22]\]

In our study, all vehicles exhibited antimicrobial activity at 100% concentration. We chose broth dilution over agar well diffusion, as the diffusion of vehicles through agar would be difficult due to them being viscous. Of them, propylene glycol exhibited maximum activity against *En. faecalis*, which was otherwise the least susceptible to the remaining vehicles. In 1965, Olitzky reported that propylene glycol is a known antimicrobial with marked germicidal activity.\[[@ref23]\] Glycerine exhibited activity only at 100% concentration and, therefore, was the least effective antimicrobial. This is in accordance with the results observed by Antony *et al*. in 1997.\[[@ref24]\] Other studies demonstrated bactericidal activity at 30% and 25% concentration but at a longer incubation time, i.e. after 48 h and 7 days, which is contrary to the findings of the present study.\[[@ref25]\]

PEG 400, glycerine, and propylene glycol combination with PEG 400 showed similar bactericidal activity at 100% concentration only, against all the selected organisms. PEG 1000 showed bactericidal activity at the lowest concentration, i.e. at 25% against *Str. mutans* and *Es. coli*, but it exhibited bactericidal activity against *Sta. aureus* and *En. faecalis*, the most resistant of the selected standard strains, at 100% concentration only.

*Str. mutans* and *Es. coli* were the most susceptible organisms. Susceptibility of *Str. mutans* and *Es. coli* to 25% of PEG 1000 is in accordance with the findings by Carreira *et al*., but the results of *Sta. aureus* and *En. faecalis* vary and are not in agreement, which might be due to the selection of different standard strains. The results of the antimicrobial activity of PEG 400 and glycerine are contrary to the findings of Gomes *et al*., which could be because they had used agar diffusion method to test the antimicrobial activity. The negative results may be due to their inability to diffuse through agar due to their viscous nature and not necessarily due to the absence of antimicrobial activity.\[[@ref12][@ref26]\] Both PEG and propylene glycol possess low toxicity and are well-recognized vehicles for drugs.\[[@ref10][@ref27]\] Also, they result in better handling properties of the resulting paste.\[[@ref22]\] Combination of propylene glycol with PEG 400 exhibited a non-synergistic effect. PEG 400 has an inherent advantage that it does not interact with other components of the paste and exerts its antibacterial activity because it has a low water activity.\[[@ref28]\]

CONCLUSION {#sec1-5}
==========

The purpose of conducting this study was to test the bactericidal activity of the above-mentioned vehicles and to determine the vehicle with the maximum bactericidal activity. This will aid in enhancing the diffusion, antimicrobial activity, and release of the intracanal medicaments for a longer period of time.\[[@ref9]\] Hence, the most effective antimicrobial vehicle has its applications in Endodontics as an intracanal medicament,\[[@ref4]\] in Pedodontics for lesion sterilization and tissue repair,\[[@ref11][@ref18]\] in chronic periodontitis for local drug delivery,\[[@ref16]\] and also in the emerging field of Regenerative Endodontics.\[[@ref29]\] The use of vehicles with good bactericidal activity might reduce the usage of antibiotics and toxic substances like CMCP and encourage the use of innovative substances like chlorhexidine gluconate as intracanal medicaments which do not develop resistance and are more biocompatible.\[[@ref30]\]

Within the limitations of this study, of all the vehicles, PEG 1000 followed by propylene glycol were found to have better antimicrobial and bactericidal activities. Also, it had better handling properties of the resulting paste and diffusion through dentinal tubules.\[[@ref9][@ref12]\] The use of combination of propylene glycol with PEG 400 is not justified. PEG 1000 has greater bactericidal activity on *Str. mutans* and *Es. coli*.

Further studies should be carried out to verify and compare the diffusion of all the vehicles through dentinal tubules and against clinical isolates *in vitro*. Due to the synergistic action or even nullifying effect of combination of these vehicles with various intracanal medicaments, for instance, commonly used antibiotics, *in vitro* studies should be carried out to find the best medicament and vehicle combination, followed by *in vivo* studies.
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